#ELEG Electric Guitar PLC – Proposed acquisition: oil & gas assets in Oklahoma April 29, 2026 – Posted in: Electric Guitar Plc (ELEG)

As announced on 30 March 2026, the Board of Electric Guitar PLC (the “Board”) is continuing discussions regarding the acquisition of Dunbar Energy Inc. (“Dunbar”), although this has been delayed by the changing nature of Dunbar’s asset base and structuring matters as Dunbar continues to develop its strategy in the USA of behind-the-meter (“BTM”) power from gas wells to local intensive compute sites. While discussions have been continuing with Dunbar, the Board has been introduced…

Continue reading

#VELA investee co. #ENSI EnSilica PLC – New Debt Facility November 4, 2024 – Posted in: Uncategorized

EnSilica, a leading chip maker of mixed signal ASICs (Application Specific Integrated Circuits), is pleased to announce that it has secured a new debt facility to refinance its existing external loan facilities, providing total funding of up to £9 million and extending out to November 2029 (the “Facility”).   The Facility has been agreed with Lloyds Bank Group plc, providing the Company with additional flexibility to underpin ongoing working capital commitments, and ensuring that EnSilica…

Continue reading

#TSP Truspine Technologies PLC – Convertible Loan, Loan Update, AGM Update and RPT February 14, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £50,000 convertible loan note agreement with Martin Armstrong (the “CLN Agreement”), the former Non-Executive Chairman of the Company. The Company also provides an update on the loan agreement announced on 5 January 2024 and on its 2022 annual general meeting (“2022 AGM”) which is due to be convened.   CLN Agreement Pursuant to the…

Continue reading

#TSP Truspine Technologies PLC – Loan, Related Party Transaction and FDA Update January 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £30,000 loan agreement with Annabel Schild (the “Loan Agreement”), a former Non-Executive Director of the Company within 12 months of the Loan Agreement being entered into and therefore is considered a related party pursuant to the AQSE Growth Market Access Rulebook. The Company also provides an update on its U.S. Food and Drug Administration…

Continue reading